Scarica l'app Stockscreener
11.05
0.09%
-0.010
Dopo l'orario di chiusura:
11.10
0.05
+0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.06
Aprire:
$11.61
Volume 24 ore:
2.84M
Relative Volume:
1.33
Capitalizzazione di mercato:
$1.45B
Reddito:
$260.11M
Utile/perdita netta:
$60.64M
Rapporto P/E:
25.70
EPS:
0.43
Flusso di cassa netto:
$92.29M
1 W Prestazione:
-15.00%
1M Prestazione:
-7.84%
6M Prestazione:
+37.44%
1 anno Prestazione:
+50.75%
Intervallo 1D:
$11.04
$11.65
Intervallo di 1 settimana:
$10.34
$13.54
Portata 52W:
$6.55
$13.54
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Nome
Aurinia Pharmaceuticals Inc
Settore
Industria
Telefono
250-744-2487
Indirizzo
#140, 14315 - 118 AVENUE, EDMONTON, BC
Confronta AUPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
11.05 | 1.46B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Ripresa | H.C. Wainwright | Buy |
| 2022-11-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-05-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-01-25 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-05-05 | Iniziato | Cowen | Outperform |
| 2020-01-10 | Iniziato | Jefferies | Buy |
| 2019-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-16 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-02-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-22 | Reiterato | FBR & Co. | Outperform |
| 2016-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-17 | Reiterato | H.C. Wainwright | Buy |
| 2016-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2015-05-08 | Iniziato | MLV & Co | Buy |
Mostra tutto
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
Aurinia Defends Benefit/Risk Profile of Lupus Nephritis Treatment After FDA Official's Retracted LinkedIn Post - MarketScreener
Aurinia Pharma rises after defending lupus drug - TradingView
Aurinia Sinks After FDA Official Questions Its Drug in Post - Bloomberg.com
Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha
Will earnings trigger a reversal in Aurinia Pharmaceuticals Inc.Gap Down & Smart Money Movement Alerts - newser.com
Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - MSN
Can Aurinia Pharmaceuticals Inc. (IKAP) stock reach $200 price target2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD By Investing.com - Investing.com Nigeria
Aurinia Responds to Now Retracted LinkedIn Post - Business Wire
Why retail investors pile into Aurinia Pharmaceuticals Inc. stockWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Pharma company Aurinia falls after FDA official uses LinkedIn to call out lupus drug - Sherwood News
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 52-Week HighHere's Why - MarketBeat
Aurinia drops after FDA official criticizes voclosporin - TipRanks
Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn - Bloomberg.com
Pattern recognition hints at Aurinia Pharmaceuticals Inc. upside2025 Earnings Surprises & Fast Moving Market Watchlists - newser.com
Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD - Investing.com
Can swing trading help recover from Aurinia Pharmaceuticals Inc. lossesJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
How high can Aurinia Pharmaceuticals Inc. stock goMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Analyzing net buyer seller activity in Aurinia Pharmaceuticals Inc.2025 Retail Activity & Reliable Volume Spike Trade Alerts - newser.com
Will Aurinia Pharmaceuticals Inc. price bounce be sustainableWeekly Trend Summary & Entry Point Confirmation Signals - newser.com
Using AI based signals to follow Aurinia Pharmaceuticals Inc.July 2025 Outlook & Daily Entry Point Alerts - newser.com
Is Aurinia Pharmaceuticals Inc a good long term investmentConsumer Goods Stocks & Build Wealth With Strategy - Early Times
Strs Ohio Buys New Shares in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aurinia Pharmaceuticals Hits New 52-Week High of $13.44, Up 142% - Markets Mojo
Acropolis Investment Management LLC Invests $242,000 in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aurinia Pharmaceuticals stock hits 52-week high at 13.12 USD By Investing.com - Investing.com Nigeria
Aurinia Pharmaceuticals Hits New 52-Week High of $13.05, Up 140.74% - Markets Mojo
Aurinia Pharmaceuticals stock hits 52-week high at 13.12 USD - Investing.com India
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 1-Year HighHere's What Happened - MarketBeat
Aurinia Pharmaceuticals stock climbs on insider buying - MSN
Does Aurinia Pharmaceuticals Inc. show high probability of reboundJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com
Will Aurinia Pharmaceuticals Inc. outperform the marketGlobal Markets & Stepwise Trade Execution Plans - newser.com
Does Aurinia Pharmaceuticals Inc. fit your quant trading modelPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Aurinia’s Big Bet On Lupus Nephritis Is Paying Off - Finimize
26,155 Shares in Aurinia Pharmaceuticals Inc $AUPH Bought by City Center Advisors LLC - MarketBeat
Aug Sentiment: Why is Aurinia Pharmaceuticals Inc. stock going downMarket Performance Report & Weekly Top Performers Watchlists - خودرو بانک
Activity Recap: Is Aurinia Pharmaceuticals Inc stock a smart retirement pick2025 Price Momentum & Entry and Exit Point Strategies - خودرو بانک
Nephrotic Syndrome Market Analysis: Epidemiology Insights, Therapies, Companies, DelveInsight | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers - Barchart.com
Is now a turning point for Aurinia Pharmaceuticals Inc.Rate Hike & Verified Chart Pattern Signals - newser.com
Long term hold vs stop loss in Aurinia Pharmaceuticals Inc.Day Trade & Weekly Return Optimization Plans - newser.com
Aug Closing: Can Aurinia Pharmaceuticals Inc grow without external fundingShare Buyback & Expert Verified Stock Movement Alerts - khodrobank.com
Will a bounce in Aurinia Pharmaceuticals Inc. offer an exit2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
What is the target price for Aurinia Pharmaceuticals Inc. stock2025 Winners & Losers & Technical Pattern Alert System - khodrobank.com
Aurinia stock jumps 14% on Q3 earnings, restructuring announcement - MSN
Aurinia Pharmaceuticals Inc. stock momentum explained2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Aurinia Pharmaceuticals Hits New 52-Week High of $12.90 - Markets Mojo
Trading Recap: Is Aurinia Pharmaceuticals Inc. attractive at current valuation2025 Fundamental Recap & Intraday High Probability Setup Alerts - خودرو بانک
Market Moves: Will Aurinia Pharmaceuticals Inc. stock benefit from M&A2025 Technical Overview & Low Drawdown Momentum Ideas - khodrobank.com
Patterns Watch: What is the target price for Aurinia Pharmaceuticals Inc. stockQuarterly Trade Summary & AI Enhanced Execution Alerts - خودرو بانک
Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):